Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, Massachusetts, offers life sciences solutions, analytical ...

Sage Therapeutics Inc (SAGE) reports significant prescription growth for ZURZUVAE, despite a net loss and strategic ...

Clinical Trials Market OverviewThe Clinical Trials Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As ...

The 35th Annual IFTSA and Mars Product Development Competition is a chance for students to take the skills and knowledge learned in school and apply them to a real-world situation. Each participating ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...

Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and ...

Mr. Evangelista brings over 30 years of pharmaceutical leadership ... following the acquisition of PPD, David has led global clinical development and laboratory services at PPD and LabCorp ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

They are the ones responsible for brand management, development and positioning ... them that goes beyond the traditional product facts. The pharma brand must connect with people emotionally.

Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of shareholders.